IXO Private Equity

IXO Private Equity is a prominent French private equity firm specializing in managing French General Private Equity Investment Funds (F.C.P.R.), Local Private Equity Investment Funds (F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.). The firm focuses on providing equity solutions to high-potential companies in Western and Southern France, with assets under management exceeding €800 million as of December 31, 2023. Their investment strategy encompasses both growth capital and buyout transactions, typically investing between €2 million and €30 million per project.

The firm's portfolio spans a diverse range of sectors, including biotech, health tech, fintech, artificial intelligence, and productivity tools. Notable investments include Antabio and Indy, reflecting their commitment to supporting innovative enterprises. With a dedicated team of 24 professionals, including 17 experienced investors, IXO Private Equity maintains a strong regional presence, with offices in Toulouse, Marseille, and Lyon.

IXO Private Equity is recognized and authorized by the French Financial Market Authorities (AMF) under the number GP03018. The firm is also an active participant in the UN Global Compact, demonstrating its commitment to responsible investment practices and sustainable development goals. Their approach emphasizes collaboration with public, private, and third-sector organizations to unlock comprehensive and sustainable solutions for their portfolio companies.